BioRestorative Therapies (BRTX) EBITDA (2010 - 2026)
BioRestorative Therapies (BRTX) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM BioRestorative Therapies (BRTX) EBITDA is -$14M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
BioRestorative Therapies (BRTX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +16.25% |
| 3 Years TTM | -10.52% |
| 5 Years TTM | -3.64% |
| 10 Years TTM | +6.64% |
| All Time TTM | +12.71% |
Annual EBITDA change of BioRestorative Therapies (BRTX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$3.33M | -78.43% |
| 2025 | -$15M | +35.80% |
| 2024 | -$11M | -24.50% |
| 2023 | -$15M | -20.11% |
| 2022 | -$19M | -28.11% |
| 2021 | -$26M | +896.96% |
| 2020 | -$2.63M | -67.97% |
| 2019 | -$8.21M | +10.80% |
| 2018 | -$7.41M | -8.74% |
| 2017 | -$8.12M | +7.84% |
| 2016 | -$7.53M | +8.19% |
| 2015 | -$6.96M | +44.10% |
| 2014 | -$4.83M | +3.87% |
| 2013 | -$4.65M | -15.15% |
| 2012 | -$5.48M | +58.38% |
| 2011 | -$3.46M | +71.29% |
| 2010 | -$2.02M | +68.33% |
| 2009 | -$1.20M | N/A |
Comparison BioRestorative Therapies (BRTX) five years EBITDA CAGR with competitors
BioRestorative Therapies (BRTX) five years EBITDA CAGR is -3.66%.